Term
Triamcinolone acetonide topical |
|
Definition
Kenalog®, Trianex®
Uses: Inflammatory dermatoses responsive to steroids
MOA: Inhibits multiple inflammatory cytokines, produces multiple glucocorticoid and mineralocorticoid effects
Dose: Apply q day-qid
Caution: C, ?/-, w/ skin infxn
CI: Component allergy
Disp: Cream, Oint 0.025%, 0,1%, 0.5%; Lotion 0.025%, 0.1%
SE: burning, itching, irritation, dryness, folliculitis, hypertrichosis, hypopigmentation |
|
|
Term
|
Definition
Lanoxin®, Lanoxicaps®, Digitek®
Uses: *CHF, AF, A flutter, PAT*
MOA: Positive inotrope; ↑ AV node refractory period
Dose: Adults: PO Digitalization: 0.5-0.75 mg PO, then 0.25 mg PO q6-8h to total 1-1.5 mg, IV or IM Digitalization: 0.25-0.5 mg IM or IV, then 0.25 mg q4-6 to total 0.125-0.5 mg/d PO, IM, or IV (average daily dose 0.125-0.25 mg)
Caution: C, +, w/ ↓ K+, Mg2+, renal failure
CI: AV block, idiopathic hypertrophic subaortic stenosis, constrictive pericarditis
Disp: Caps 0.05, 0.1, 0.2 mg; tabs 0.125, 0.25, 0.5 mg, elixir 0.05 mg/mL; Inj 0.1, 0.25 mg/mL
SE: Can cause heart block, ↓ K+ potentiates tox, N/V, HA, fatigue, visual disturbances (yellow-green halos, around lights), cardiac arrhythmias
Notes: Multiple drug interactions, IM inj painful, has erratic absorption & should not be used. Levels: Trough: Just before next dose; Therapeutic: 0.8-2 ng/mL, Toxic: >2 ng/mL, 1/2 life: 36h |
|
|
Term
|
Definition
Lamictal®
BBW: Serious rashes requiring hospitalization & DC of Rx reported, rash less frequent in adults, ↑ risk of suicidality for antiepileptic drug, higher for those w/ epilepsy vs. those using drug for psychological indications
Uses: *Partial szs, tonic-clonic szs, bipolar disorder, Lennox-Gastaut synd*
MOA: Phenyltriazine, antiepileptic, ↓ glutamate, stabilize neuronal membrane
Dose: Adults: Szs: Initial 50 mg/d PO, then 50 mg PO bid for x 1-2wks, maint 300-500 mg/d in 2 ÷ doses, Bipolar: Initial 25 mg/d PO x 1-2 wks, 50 mg PO daily for 2 wks, 100 mg PO daily for 1 wk, maint 200 mg/d
Caution: C, -, interactions w/ other antiepileptics, estrogen, rifampin
Disp: Tabs 25, 100, 150, 200 mg, chew tabs 2, 5, 25 mg (color-coded for those on interacting meds)
SE: Photosens, HA, GI upset, dizziness, diplopia, blurred vision, blood dyscrasias, ataxia, rash (may be much more life threatening to peds than to adults), aseptic meningitis
Notes: Value of therapeutic monitoring uncertain, taper w/ DC |
|
|
Term
|
Definition
Omnicef®
Uses: *Infxns of the resp tract, skin, bone, & urinary tract*
MOA: 3rd gen cephalosporin; ↓ cell wall synthesis; Spectrum: Many gram (+) & (-) organisms; more active than cefaclor & cephalexin against Streptococcus, Staphylococcus, some anaerobes
Dose: Adults: 300 mg PO bid or 600 mg/d Peds: 7 mg/kg PO bid or 14 mg/kg/d; ↓ in renal impair
Caution: B, +, w/ PCN-sensitive pts, serum sickness-like rxn reported
CI: Hypersensitivity to cephalosporins
Disp: Caps 300 mg, Susp 125, 250 mg/5 mL
SE: Anaplylaxis, D, rare pseudomembranous colitis |
|
|
Term
|
Definition
Cardizem® CD
Uses: *Angina, prevention of reinfarction, HTN, AF, A flutter, & PAT*
MOA: CCB
Dose: 120-360 mg/d (max 540 mg/d)
Caution: C, +, ↑ effect w. amiodarone, cimetidine, fentanyl, Li, cyclosporine, digoxin, beta blockers, theophylline
CI: SSS, AV block, ↓ BP, AMI, pulm congestion
Disp: Caps 120, 180, 240, 300 mg
SE: Gingival hyperplasia, ↓ HR, AV block, ECG abnormalities, peripheral edema, dizziness, HA
Notes: Cardizem CD, Dilacor XR & Tiazac are not interchangeable |
|
|
Term
|
Definition
Lotensin®
Uses: *HTN*, DN, CHF
MOA: ACE Inhib
Dose: 10-80 mg/d PO
Caution: C/D/D, +
CI: Angioedema, Hx edema, bilateral RAS
Disp: Tabs 5, 10, 20, 40 mg
SE: Symptomatic ↓ BP w/ diuretics, dizziness, HA, ↑ K+, nonproductive cough |
|
|
Term
|
Definition
Topamax®
Uses: *Adjunctive Rx for complex partial Szs & tonic-clonic Szs*, bipolar disorder, neuropathic pain, migraine prophylaxis
MOA: Anticonvulsant
Dose: Adults: Neuropathic pain, Szs: Total dose 400 mg/d; see PI for 8 wk titration schedule. Migraine prophylaxis: titrate 100 mg/d total
Caution: C, ?/-
CI: Component allergy
Disp: Tabs 25, 50, 100, 200 mg, cap sprinkles 15, 25, 50 mg
SE: Wgt loss, memory impair, metabolic acidosis, kidney stones, fatigue, dizziness, psychomotor slowing, paresthesias, GI upset, tremor, nystagmus, acute glaucoma requiring DC
Notes: Metabolic acidosis responsive to ↓ dose or DC, DC w/ taper |
|
|
Term
|
Definition
Imdur®
Uses: *Prevention/Rx of angina pectoris*
MOA: Relaxes vascular smooth muscle
Dose: 5-10 mg PO bid, w/ the 2 doses 7 hrs apart or XR (Imdur) 30-60 mg/d PO, max 240 mg
Caution: C, ?
CI: Head trauma/cerebral hemorrhage (can ICP), w/ sildenafil, tadalafil, vardenafil
Disp: Tabs 10, 20 mg, XR 30, 60, 120 mg
SE: HA, dizziness, ↓ BP |
|
|
Term
|
Definition
Altace®
BBW: ACE inhib used during PRG can cause fetal injury & death
Uses: *HTN, CHF, DN, post-MI*
MOA: ACE inhib
Dose: 2.5-20 mg/d PO ÷ daily-bid; ↓ in renal failure
Caution: D, +
CI: ACE-inhib induced angioedema
Disp: Caps 1.25, 2.5, 5, 10 mg
SE: Cough, HA, dizziness, ↓ BP, renal impair, angioedema
Notes: OK in combo w/ diuretics |
|
|
Term
|
Definition
Risperidal®, Risperidal® M-Tab
BBW: ↑ Mortality in elderly w/ dementia-related psychosis
Uses: *Psychotic disorders (schizophrenia)*, dementia of the elderly, bipolar disorder, mania, Tourette disorder, autism
MOA: Benzisoxazole antipsychotic
Dose: Adults: 0.5-6 mg PO bid, M-Tab: 1-6 mg start 1-2 mg/d, titrate q3-7 d
Caution: C, -, ↑ BP w/ antihypertensives, clozapine
CI: Component allergy
Disp: Tabs 0.25, 0.5, 1, 2, 3, 4 mg; soln 1 mg/mL, M-Tab 0.5, 1, 2, 3, 4 mg
SE: Orthostatic ↓ BP, EPS w/ high dose, tachycardia, arrhythmias, sedation, dystonias, neuroleptic malignant syndrome, sexual dysfunction, constipation, xerostomia, ↓ WBC, neutropenia, agranulocytosis, cholestatic jaundice
Notes: Serveral wk for effect |
|
|
Term
|
Definition
DiaBeta®, Micronase®, Glynase®
Uses: *Type 2 DM*
MOA: Sulfonylurea; ↑ pancreatic insulin release, ↑ peripheral insulin sensetivity, ↓ hepatic glucose output/production, ↓ intestinal glucose absorption
Dose: 1.25-10 mg daily-bid, max 20 mg/d. Micronized: 0.75-6 mg daily-bid, max 12 mg/d
Caution: C, ?, renal impair, sulfonamide allergy
CI: DKA, type 1 DM
Disp: Tabs 1.25, 2.5, 5 mg; micronized tabs 1.5, 3, 6 mg
SE: HA, hypoglycemia, cholestatic jaundice, and hepatitis may cause liver failure
Notes: Not OK for CrCl <50 mL/min; hold dose if NPO; hypoglycemia may be difficult to recognize; many medications can enhance hypoglycemic effects |
|
|
Term
|
Definition
Pen-Vee K®
Uses: Susceptible streptococcal infxns, otitis media, URIs, skin/soft-tissue infxns (PCN-sensitive staphylococci)
MOA: Bactericidal; ↓ cell wall synthesis. Spectrum: Most gram (+), including streptococci
Dose: Adults: 250-500 mg PO q6h, q8h, q12h, ↓ in renal impair; take on empty stomach
Caution: B, M
CI: Allergy
Disp: Tabs 125, 250, 500 mg; susp 125, 250 mg/5mL
SE: GI upset, intersitial nephritis, anaphylaxis, convulsions
Notes: Well-tolerated PO PCN; 250 mg= 400,000 units of PCN G |
|
|
Term
|
Definition
Prevacid®
Uses: *Duodenal ulcers, prevent & Rx NSAID gastric ulcers, active gastric ulcers, H. pylori infxns, erosive esophagitis & hyperscretory conditions, GERD*
MOA: Proton pump inhib
Dose: 15-30 mg/d PO; NSAID ulcer prevention: 15 mg/d before food; 30 mg IV daily= 7 d change to PO for 6-8 wk; ↓ w/ severe hepatic impair
Caution: B, ?/-, may ↓ effect of Plavix
Disp: Prevacid: DR caps 15, 30 mg; ODT: 15, 30 mg (contains phenylalanine), IV 30 mg
SE: N/V, Abd pain, HA, fatigue
Notes: For IV provided inline filter must be used; do not crush/chew; granules can be given w/ applesauce or apple juice (NG tube) only; ? ↑ risk of fractures w/ all PPI |
|
|
Term
|
Definition
Cleocin®
BBW: Pseudomembranous colitis may range from mild to life-threatening
Uses: *Rx aerobic & anaerobic infxns, topical for severe acne & vag infxns*
MOA: Bacteriostatic; interferes w/ protein synth. Spectrum: Streptococci, pneumococci, staphylococci & gram (+) & (-) anaerobes; no activity against gram (-) aerobes
Dose: Adults: PO: 150-450 mg PO q6-8h. IV: 300-600 mg IV q6h or 900 mg IV q8h. Vaginal: 1 applicator hs for 7 days. Topical: Apply 1% gel lotion, or soln bid
Caution: B, +, Can cause fatal colitis
CI: Hx pseudomembranous colitis
Disp: Caps 75, 150, 300 mg; susp 75 mg/5 mL; Inj 300 mg/2 mL; vag cream 2%; top soln, gel, lotion 1%; vag supp 100 mg
SE: D may be C. difficile pseudomembranous colitis, ↑ LFTs, rash
Notes: D/C drug w/ D, evaluate for C. difficile |
|
|
Term
|
Definition
Wellbutrin® XL
BBW: All pts being treated w/ buproprion for smoking cessation Tx should be observed for neuropsychiatric S&Sxs (hostility, agitation, depressed mood, and suicide-related events; most during/after Zyban; Sxs may persist following DC; Closely monitor for worsening depression or emergence of suicidality, increased suicidal behavior in young adults
Uses: *Depression, smoking cessation adjunct*, ADHD
MOA: Weak inhib of neuronal uptake of serotonin & NE; ↓ neuronal dopamine reuptake
Dose: Depression: 100-450 mg/d ÷ bid-tid; XL: 150-450 mg/d. Smoking cessation: 150 mg/d x 3d, then 150 mg bid x 8-12 wks, last dose before 6 pm; ↓ dose w/ renal/hepatic impair
Caution: C, ?/-
CI: Sz disorder, Hx anorexia nervosa or bulimia, MAOI w/ or w/in 14 d; abrupt DC of EtOH or sedatives; inhibitors/inducers of CYP 2B6; w/ ritonavir and lopinavir/ritonavir
Disp: Tabs 75, 100 mg; SR tabs 100, 150, 200 mg; XL tabs 150, 300 mg; Zyban 150 mg tabs
SE: Szs, agitation, insomnia, HA, tachycardia, ↓ wgt
Notes: Avoid EtOH & other CNS depressants, SR & XR do not crush/chew/cut, may ↑ adverse events including szs |
|
|
Term
|
Definition
Flagyl®, Metrogel®
BBW: Carcinogenic in rats
Uses: *Bone/joint, endocarditis, intra-Abd, meningitis, & skin infxns; amebiasis and amebic liver abcess; trichomoniasis in pt and partner; bacterial vaginosis; PID; giardiasis; antibiotic associated pseudomembranous colitis (C. difficle), eradicate H. pylori w/ combo Rx, rosacea, prophylactic in post-op colorectal surgery*
MOA: Interfers w/ DNA synthesis, Spectrum: Excellent anaerobic, C. difficile
Dose: Adults: Anaerobic infxns: 500 mg IV q6-8h. Amebic dysentery: 500-750 mg/d PO q8h x 5-10 d. Trichomonas: 250 mg PO tid for 7 d or 2 g PO x 1 (Rx partner). C difficile: 500 mg PO or IV q8h for 7-10 d (PO preferred; IV only if pt is NPO), if no response switch to PO vanco. Vaginosis: 1 applicator intravag q day or bid x 5d, or 500 mg PO bid x 7 d or 750 mg PO q day x 7 d. Acne rosacea/skin: Apply bid. Giardia: 500 mg PO bid x 5-7 d. H pylori: 250-500 mg PO w/ meals & hs x 14 d, combine w/ other antibiotic & a PPI or H2 antagonist, ↓ w/ severe hepatic/renal impair
Caution: B, +/-, Avoid EtOH, w/ warfarin, CYP 3A4 substrates, ↑ Li levels
CI: First tri of PRG
Disp: Tabs 250, 500 mg; XR tabs 750 mg; caps 375 mg; IV 500 mg/100 mL; lotion 0.75%; gel 0.75, 1%; intra vag gel 0.75%; cream 0.75, 1%
SE: Disulfuram-like rxns, dizziness, HA, GI upset, anorexia, urine discoloration, flushing, metallic taste
Notes: For trichomoniasis, Rx pts partner, no aerobic bacteria activity, use in combo w/ serious mixed infxns, wait 24 h after 1st dose to breast-feed or 48h if extended Rx, take ER on empty stomach |
|
|
Term
|
Definition
Glucotrol®, Glucotrol® XL
Uses: *Type 2 DM*
MOA: Sulfonylurea; ↑ peripheral insulin sensitivity; ↓ hepatic glucose output/production, ↓ intestinal glucose absorption
Dose: 5 mg initial, ↑ by 2.5-5 mg/d, max 40 mg/d; XL max 20 mg/d; 30 min ac; hold if NPO
Caution: C, ?/-, severe liver Dz
CI: DKA, type 1 DM, sulfonamide sensitivity
Disp: Tabs 5, 10mg; XL 2.5, 5, 10 mg
SE: HA, anorexia, N/V/D, constipation, fullness, rash, urticaria, photosens
Notes: Counsel about DM management, wait several days before adjusting dose, monitor glucose |
|
|
Term
|
Definition
Depakote®, Depakene®
BBW: Fatal hepatic failure (usually during 1st 6 mo of tx, peds < 2 yrs high risk, monitor LFTs at baseline and frequent intervals), teratogenic effects, and life-threatening pancreatitis reported
Uses: *Rx epilepsy, mania, prophylaxis of migraines*, Alzheimer behavior disorder
MOA: Anticonvulsant; ↑ availability of GABA
Dose: Szs: 30-60 mg/kg/24 h PO ÷ tid (after initiation of 10-15 mg/kg/24 h) Mania: 750 mg in 3 ÷ doses, ↑ 60 mg/kg/d max. Migraines: 250 mg bid, ↑ 1000 mg/d max; ↓ w/ hepatic impair
Caution: D, +, multiple drug interactions
CI: Severe hepatic impair, urea cycle disorder
Disp: Caps 250 mg; Caps w/ coated particles 125 mg; tabs DR 125, 250, 500 mg; tabs ER 250, 500 mg; Caps DR 125, 250, 500 mg; syrup 250 mg/5 mL; Inj 100 mg/mL
SE: Somnolence, dizziness, GI upset, diplopia, ataxia, rash, thrombocytopenia, ↓ plt, hep, pancreatitis, ↑ wgt, ↑ hyperammonemic encephalopathy in pts w/ urea cycle disorders
Notes: Monitor LFTs & levels; trough: just before next dose; Therapeutic: Peak: 50-100 mcg/mL; Toxic Trough: >100 mcg/mL. Half-life: 5-20 h; phenobarbital & phenytoin may alter levels |
|
|
Term
|
Definition
Ortho-Tri-Cyclen®
BBW: Smoking may increase the risk of serious cardiovascular SE. This risk is increased in women >35 years old
Uses: *Contraception, acne vulgaris*, dysfunctional uterine bleeding, dysmenorrhea, endometriosis, PCOS
MOA: Suppresses LH and FSH, inhibiting ovulation; alters cervical mucusand endometrium
Dose: 1 tablet daily
Caution: X, +, w/ hepatic/renal impair, HTN, hyperlipdiemia, DM, gallbladder Dz
CI: Hx of breast CA or endometrial CA, active hepatic dz, cholestatic jaundice, uncontrolled HTN, Hx or risk factors of clot
Disp: Norgestimate 0.18 mg/ Ethinyl estradiol 35 mcg x 7 tabs, 0.215 mg/35 mcg x 7 tabs, 0.25 mg/35 mcg x 7 tabs, then 7 inert tabs
SE: bleeding irregularities, N/V, HA, breast tenderness, edema, wgt changes, depression, libido changes, glucose intolerance, elevated BP |
|
|
Term
|
Definition
Cozaar®
BBW: Can cause fatal injury and death if used in 2nd & 3rd trimesters. DC Rx if PRG detected
Uses: *HTN, DN, prevent CVA in HTN, and LVH*
MOA: Angiotensin II receptor antagonist
Dose: 25-50 mg PO daily-bid, max 100 mg; ↓ in elderly/hepatic impair
Caution: C/D/D, ?/-, w/ NSAIDs, w/ K+ sparing diuretics, supl may cause ↑ K+, w/ RAS, hepatic impair
CI: PRG, component sensitivity
Disp: Tabs 25, 50, 100 mg
SE: ↓ BP in pts on diuretics, ↑ K+, GI upset, facial/angioedema, dizziness, cough, weakness, ↓ renal fxn |
|
|
Term
|
Definition
K-DUR®
Uses: Prevention or Rx of ↓ K+
MOA: K+ supl
Dose: 20-100 mEq/d PO ÷ daily-bid, IV 10-20 mEq/h, max 40 mEq/h & 150 mEq/d (monitor K+ levels frequently and in presence of continuous ECG monitoring w/ high dose IV
Caution: A, +, renal insuff, use w/ NSAIDs & ACE inhib
CI: ↑ K+
Disp: 8, 10, 20 mEq tabs
SE: GI irritation, ↓ HR, ↑ K+, heart block
Notes: Mix powder & liq w/ beverage (unsalted tomato juice, etc.), swallow SR tabs whole, monitor K+, Cl- salt OK w/ alkalosis, w/ acidosis use acetate, bicarbonate, citrate, or gluconate salt. Do not administer IV K+ undiluted |
|
|
Term
|
Definition
Adipex-P®
Uses: Short-term tx of obesity
MOA: Stimulates CNS activity; antiobesity agent
Dose: 18.75-37.5 mg PO qAM, 1-2 hrs before breakfast
Caution: C, -, elderly pts, HTN, DM
CI: PRG, Breastfeeding, CVD, HTN, glaucoma, Hx of drug abuse
Disp: Tabs 37.5
SE: palpitations, tachycardia, HTN, restlessness, insomnia, dizziness, euphoria, tremor, HA, xerostomia, constipation, D, itching
Notes: Do not crush or chew. May be split in half |
|
|
Term
|
Definition
Remeron®, Remeron® SoluTab
BBW: ↑ Risk of suicidal thinking and behavior in children, adolescents, and young adults w/ major depression and other psychological disorders. Not for peds
Uses: *Depression*
MOA: Alpha-2 antagonist antidepressant; ↑ NE & 5-HT
Dose: 15 mg PO hs, up to 45 mg/d
Caution: C, ?, has anticholesterol effects, w Sz, clonidine, CNS depressant use, CYP 1A2, 3A4 inducers/inhib
CI: MAOIs w/in 14 d
Disp: Tabs 15, 30, 45 mg: rapid dispersion tabs 15, 30, 45 mg
SE: Somnolence, ↑ cholesterol, constipation, xerostomia, wgt gain, agranulocytosis, ↓ BP, edema, musculoskeletal pain
Notes: Do not ↑ dose < q1-2 wks, handle rapid tabs w/ dry hands, do not cut or chew |
|
|
Term
|
Definition
Atarax®, Vistaril®
Uses: *Anxiety, sedation, itching*
MOA: Antihistamine, antianxiety
Dose: Anxiety/sedation: 50-100 mg PO or IM qid or PRN (max 600 mg/d) Itching: 25-50 mg PO or IM tid-qid, ↓ w/ hepatic impair
Caution: C, +/-, ↑ effects w/ CNS depressants, anticholinergics, EtOH
CI: Component sensitivity
Disp: Tabs 10, 25, 50 mg; Caps 25, 50 mg; syrup 10 mg/5 mL; susp 25 mg/5 mL; Inj 25, 50mg/mL
SE: Drowsiness, anticholinergic effects
Notes: Used to potentiate narcotic effects; not for IV/SQ (thrombosis & digital gangrene possible) |
|
|
Term
|
Definition
Estrace®
BBW: ↑ Risk of endometrial CA; avoid in PRG
Uses: *Atrophic vaginitis, menopausal vasomotor Sxs, ↑ low estrogen levels, pallitation breast amd PCa*
MOA: Estrogen
Dose: PO: 1-2 mg/d, adjust PRN to control Sxs, Vaginal cream: 2-4 g/d x 2 wks, then 1 g 1-3x/wk. Vasomotor Sx/Vag Atrophy: 10-20 mg IM q4wk, DC or taper at 3-6 mo intervals. Hypoestrogenism: 10-20 mg IM q4wk. PCa: 30 mg IM q12wk
Caution: X, -
CI: Genital bleeding of unknown cause, breast CA, porphyria, estrogen-dependent tumors, thromboembolic disorders, thrombophlebitis, recent MI, hepatic impair
Disp: Tabs 0.5, 1, 2 mg
SE: N, HA, bloating, breast enlargement/tenderness, edema, ↑ triglycerides, venous thromboembolism, gallbladder Dz |
|
|
Term
|
Definition
Valtrex®
Uses: *Herpes zoster, genital herpes, herpes labialis*
MOA: Prodrug of acyclovir, ↓ viral DNA replication. Spectrum: Herpes simplex I & II
Dose: Zoster: 1 g PO tid x 7 d. Genital herpes (initial episode): 1 g PO bidx 7-10 d, (recurrent): 500 mg PO bid x 3 d or 1 g PO qday x 5d. Herpes prophylaxis: 500-1000 mg/d. Herpes labialis: 2 g PO q12h x 1 d, ↓ w/ renal failure
Caution: B, +, ↑ CNS effects in elderly
Disp: Caplets 500, 1000 mg
SE: HA, GI upset, dizziness, pruritis, photophobia |
|
|
Term
|
Definition
Voltaren®
BBW: May ↑ risk of CV events & GI bleeding; CI in post-op CABG
Uses: *Athritis & pain, oral and topical actinic keratosis*
MOA: NSAID
Dose: 50-75 mg PO bid w/ food or milk
Caution: C, ?, CHF, HTN, renal/hepatic dysfunction & Hx PUD , asthma
CI: NSAID/aspirin ASA allergy, porphyria, following CABG
Disp: Tabs 50 mg, tabs DR 25, 50, 75, 100 mg, XR tabs 100 mg
SE: Abd cramps, heartburn, GI ulcerations, rash, intersitial nephritis
Notes: Do not crush tabs, watch for GI bleed, check CBC, LFTs periodically |
|
|
Term
Nitrofurantion monohydrate |
|
Definition
MacroBid®
BBW: Pulm fibrosis possible
Uses: *Prophylaxis & Rx of UTI*
MOA: Bacteriocidal; interferes w/ carbohydrate metabolism. Spectrum: Some gram (+) & (-) bacteria: Pseudomonas, Serratia, & most Proteus resistant
Dose: Prophylaxis: 50-100 mg/d PO. Rx: 50-100 mg PO qid x 7 d. Macrobid: 100 mg PO bid x 7 d
Caution: B, +/not OK if child < 1 mo, avoid w/ CrCl <60 mL/min
CI: Renal failure, infants < 1 mo, PRG at term
Disp: Caps 25, 50, 100 mg; Susp 25 mg/5 mL
SE: GI effects, dyspnea, various acute/chronic pulm Rxns, peripheral neurpathy, hemolytic anemia w/ G6PD deficiency, rare aplastic anemia
Notes: Macrocrystals (Macrodantin) < N than other forms, not for comp UTI, may turn urine brown |
|
|
Term
|
Definition
Calan® SR
Uses: *Angina, HTN, PSVT, AF, A flutter*, migraine prophylaxis, hypertrophic cardiomyopathy, bipolar Dz
MOA: CCB
Dose: Arrhythmias: 5-10 mg in 15-30 min PRN (30 mg Max). Angina: 80-120 mg PO tid, ↑ 480 mg/24 h, max. HTN: 120-240 mg PO daily to 240 mg bid
Caution: C, +, amiodarone/beta-blockers/flecanide can cause ↓ HR statins, midazolam, tacrolimus, theophylline levels may be ↑; use w/ clonidine may cause severe ↓ HR w/ elderly pts
CI: Conduction disorders, cardiogenic shoch, Beta blockers/thiazide combo, dofetilide, pimozide, ranolazine
Disp: Caps 120, 180, 240, 360 mg
SE: Gingival hyperplasia, constipation, ↓ BP, bronchospasm, HR or conduction disturbances, ↓ BP and bradyarrhythmias taken w/ telithromycin |
|
|
Term
|
Definition
Effexor® XR
BBW: Monitor for worsening depression or emergence of suicidality, particularly in ped pts
Uses: *Depression, generalized anxiety, social anxiety disorder, panic disorder*, OCD, chronic fatigue synd, ADHD, autism
MOA: Potentiation of CNS neurotransmitter activity
Dose: 75-225 mg/d ÷ into 2-3 equal doses (IR) or qday (ER); 375 mg IR or 225 mg ER max/d, ↓ w/ renal/hepatic impair
Caution: C, ?/-
CI: MAOIs
Disp: tabs IR 25, 37.5, 50, 75, 100 mg; ER caps 37.5, 75, 150 mg
SE: HTN, ↑ HR, HA, somnolence, GI upset, sexual dysfxn, actuates mania or Szs
Notes: Avoid EtOH |
|
|